Plasma ALT, cholesterol, plasma and hepatic TG, and FFA levels were significantly decreased in ob/ob mice treated with UDCA (Table 3), suggesting UDCA ameliorated obesity and altered lipid metabolism. The gene discussed is GPT; the disease is obesity disorder.